These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30595300)

  • 1. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis.
    Fajar JK; Heriansyah T; Rohman MS
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S406-S418. PubMed ID: 30595300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Refaat H; Tantawy A; Gamal AS; Radwan H
    Indian Heart J; 2021; 73(1):35-43. PubMed ID: 33714407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Gupta S; Gupta MM
    Indian Heart J; 2016; 68(4):539-51. PubMed ID: 27543480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Tasar O; Karabay AK; Oduncu V; Kirma C
    Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Somuncu MU; Akgun T; Cakır MO; Akgul F; Serbest NG; Karakurt H; Can M; Demir AR
    J Atheroscler Thromb; 2019 Nov; 26(11):970-978. PubMed ID: 30996145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.
    Ma M; Wang L; Diao KY; Liang SC; Zhu Y; Wang H; Wang M; Zhang L; Yang ZG; He Y
    BMC Cardiovasc Disord; 2022 Feb; 22(1):30. PubMed ID: 35120436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Maria DA; Allaithy A
    Glob Heart; 2022; 17(1):23. PubMed ID: 35586740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.
    Kumar R; Khan KA; Shah JA; Ammar A; Kumar D; Khowaja S; Sial JA; Kazmi S; Murtaza M; Karim M
    J Ayub Med Coll Abbottabad; 2022; 34(2):288-294. PubMed ID: 35576288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum.
    Sabin P; Koshy AG; Gupta PN; Sanjai PV; Sivaprasad K; Velappan P; Vellikat Velayudhan R
    Indian Heart J; 2017 Apr; 69 Suppl 1(Suppl 1):S34-S45. PubMed ID: 28400037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST Segment Resolution After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction With Initial Thrombolysis in Myocardial Infarction Grade 0.
    Kai T; Oka S; Hoshino K; Watanabe K; Nakamura J; Abe M; Watanabe A
    Circ J; 2021 Sep; 85(10):1770-1778. PubMed ID: 34305099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Li Q; Xie E; Tu Y; Wu Y; Guo Z; Li P; Li Y; Yu X; Ye Z; Yu C; Gao Y; Jingang Z
    Int J Cardiol; 2022 Dec; 369():13-18. PubMed ID: 35970443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Allaithy A; Maria DA
    Anatol J Cardiol; 2022 May; 26(5):382-387. PubMed ID: 35552174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.